KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Treasury Shares (2016 - 2026)

Bristol Myers Squibb has reported Treasury Shares over the past 18 years, most recently at $43.5 billion for Q1 2026.

  • Quarterly Treasury Shares changed 0.19% to $43.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $43.5 billion through Mar 2026, changed 0.19% year-over-year, with the annual reading at $43.6 billion for FY2025, 0.17% changed from the prior year.
  • Treasury Shares was $881.0 million for Q1 2026 at Bristol Myers Squibb, down from $887.0 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $896.0 million in Q1 2024 and troughed at $12.0 million in Q3 2022.
  • The 5-year median for Treasury Shares is $881.0 million (2026), against an average of $719.5 million.
  • Year-over-year, Treasury Shares increased 29.37% in 2022 and then dropped 0.25% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $38.6 billion in 2022, then grew by 13.33% to $43.8 billion in 2023, then fell by 0.25% to $43.7 billion in 2024, then decreased by 0.17% to $43.6 billion in 2025, then dropped by 0.15% to $43.5 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Treasury Shares are $43.5 billion (Q1 2026), $43.6 billion (Q4 2025), and $43.6 billion (Q3 2025).